Author:
Ghaemmaghami Zahra,Alemzadeh-Ansari Mohammad Javad,Rezvani Alireza,Bari Alireza
Publisher
Springer Nature Switzerland
Reference46 articles.
1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–5.
2. Armenian SH, Bhatia S. Cardiovascular disease after hematopoietic cell transplantation–lessons learned. Haematologica. 2008;93(8):1132–6.
3. Armenian SH, Sun C-L, Vase T, Ness KK, Blum E, Francisco L, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood J Am Soc Hematol. 2012;120(23):4505–12.
4. Armenian SH, Horak D, Scott JM, Mills G, Siyahian A, Teh JB, et al. Cardiovascular function in long-term hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant. 2017;23(4):700–5.
5. Attallah H, Friedlander AL, Hoffman AR. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy. Growth Hormon IGF Res. 2006;16:62–7.